Oct. 18 2024
Source Page: Falls: assessment and prevention in older people and people 50 and over at higher risk (update)Found: , Headache, Hearing impairment, Heart failure, Housebound, Hypertension, Hypotension or syncope, Inflammatory
Asked by: Rebecca Paul (Conservative - Reigate)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will publish a strategy for ensuring people living with (a) Crohn’s disease and (b) other forms of inflammatory bowel disease are able to access treatment in a timely manner.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England’s Getting It Right First Time Programme on gastroenterology aims to reduce variations in care, increase early diagnosis and proactive management of Crohn’s disease and colitis, and increase access to inflammatory bowel disease (IBD) specialist nurses. The National institute for Health and Care Excellence has also produced a range of guidance on IBD, and Crohn’s disease and colitis, to support early diagnosis and effective management of these conditions. It ensures that the care provided to people with IBD is based on the best available evidence. In the last two years, the National Institute for Health and Care Excellence has recommended four new drugs for the treatment of moderate to severe Crohn’s disease and ulcerative colitis, including Upadacitinib, Risankizumab, Mirikizumab, and Etrasimod.
NHS England’s National Bladder and Bowel Health Project is delivering better care for people with IBD, with a focus on developing clinical pathways. NHS England commissions specialised colorectal services nationally to support equity of access to high-quality treatment for patients with IBD requiring complex surgery. This work is supported within NHS England by the clinical leadership of the Specialised Colorectal Services Clinical Reference Group, which is made up of experts in surgery, medicine, radiology, pathology, and nursing, alongside patient and public voice representatives.
To raise awareness of IBD among general practitioners and other primary care staff, the Royal College of General Practitioners has produced an Inflammatory Bowel Disease Toolkit. The toolkit outlines when to suspect IBD, the appropriate investigative tests and diagnostic tools for IBD, how to manage a flare-up of symptoms and how to support patients with IBD.
Oct. 08 2024
Source Page: Fruquintinib for previously treated metastatic colorectal cancer ID6274Found: Bowel Cancer UK. Bowel Cancer UK. Bowel cancer costs the UK £1.74 billion a year.
Sep. 19 2024
Source Page: Fosdenopterin for treating molybdenum cofactor deficiency type A [ID6264]Found: condition of the skin Infections and infestations -0.0024 Other inflammatory condition of the skin
Found: 1 Cross -Party Group on Inflammatory Bowel Disease (IBD) 18 September 2024, 6 -8pm Minute s
Found: 1 Cross -Party Group on Inflammatory Bowel Disease Annual General Meeting Wednesday 18th September
Written Evidence Sep. 03 2024
Inquiry: Engineering biologyFound: core strengths in Engineering Biology in particular novel methodology and technologies to transform disease
Aug. 29 2024
Source Page: Urinary Tract Infection (recurrent): antimicrobial prescribingFound: options that have been used to relieve symptoms in UTI include paracetamol or 39 non-steroidal anti -inflammatory
Aug. 29 2024
Source Page: Urinary Tract Infection (recurrent): antimicrobial prescribingFound: options that have been used to relieve symptoms in UTI include paracetamol or 39 non-steroidal anti -inflammatory
Aug. 22 2024
Source Page: Risankizumab for treating moderately to severely active ulcerative colitisFound: How to predict clinical relapse in inflammatory bowel disease patients.